Christopher Casley, Patent Attorney at Mewburn Ellis, handles the full range of patent work in the life sciences sector, from pre-drafting advice to drafting and prosecution of worldwide patent portfolios. He also has experience with IP due diligence and European oppositions.
HIs areas of expertise include biological therapeutics, including antibody-drug conjugates; prognostic and treatment response predictive methods, including related computational biology; cancer therapeutics, diagnostics and biomarkers, and nanomedicine.
Chris has a degree in natural sciences (pharmacology) from the University of Cambridge and a PhD from University College London, relating to the neurochemistry of Alzheimer’s disease. He carried out post-doctoral research at a multinational pharmaceutical company before joining Mewburn Ellis LLP in 2004, qualifying as a Chartered Patent Attorney in 2007 and a European Patent Attorney in 2008. He joined the partnership in 2011.
